Marrow transplantation for thalassaemia following busulphan and cyclophosphamide. [electronic resource]
- Lancet (London, England) Jun 1985
- 1355-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0140-6736
10.1016/s0140-6736(85)91784-2 doi
Actuarial Analysis Age Factors Bone Marrow Transplantation Busulfan--therapeutic use Child Child, Preschool Combined Modality Therapy Cyclophosphamide--therapeutic use Female Graft vs Host Disease--epidemiology Histocompatibility Testing Humans Infant Male Methotrexate--therapeutic use Thalassemia--therapy